Skip to main content
OpenTrials
Completed

NCT Number: NCT03557476

Effects of Octacosanol During Taekwondo Training

Taekwondo players undergo rapid reductions of body weight prior to their competition in order to gain a size advantage over the opponent. However, these large weight changes with concomitant high intensity exercise training induce poor lipid profiles and high levels of oxidative stress, which can be detrimental to health and sports performance. Therefore, the purpose of this study was to investigate the ability of the nutritional supplement octacosanol to combat the physiological detriments that can occur from these rapid weight changes paired with high intensity exercise training.

Completed

Looking for future studies?

Notify Me

Key information

Age range

17 year–19 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

University of Nebraska at Omaha

Omaha, Nebraska, 68182, United States

About this study

Athletes that participate in weight division sports such as taekwondo, boxing, judo, and wrestling regularly reduce their body weight severely prior to competition in order to gain a size advantage over the opponent while simultaneously meeting their weight division requirements. In general, athletes have acute weight loss of 4-7 kg within 3-4 days of competition, while longer periods of more gradual weight loss of 15-22 kg lasting 3-4 weeks. Although this kind of extreme weight loss can induce metabolic dysfunction, it is repeatedly performed by athletes of weight division sports in order to acquire a more advantageous condition for play. Furthermore, athletes participating in matches tend to obtain excessive weights compared to their weight division during the offseason in order to lift heavier weights during training, and then rapidly lose that weight over a short period of time prior to competition, resulting in the deterioration of physiological function and possibly sports performance.

Rapid weight loss with high intensity exercise training also increases oxygen free radical production to a point that exceeds the defense mechanism of antioxidant enzymes in the body and ultimately results in damage to the cells, specifically, the lipid peroxidation of cell membranes. Not only does this decrease physiological function, but sports performance can also decrease as oxidative stress increases due to an interference in metabolic activity, a reduction in vascular function and an increase in systemic inflammation. Octacosanol, a straight-chain, high-molecular-weight, primary aliphatic alcohol minimally contained in the germinal disks of rice bran, wheat and sugar cane, may be able to prevent these deteriorations as it has been shown to provide various health benefits. In fact, previous studies reported that pre-exercise octacosanol intake contributed to enhanced muscular strength, muscular endurance and oxygen transport ability. Additionally, octacosanol supplementation has been shown to improve cardiovascular endurance and heart function in patients with peripheral artery disease, improve levels of low-density and high-density lipoprotein-cholesterol in patients with hypercholesterolemia, and increase glycogen accumulation in mice9. However, the potential beneficial effects of octacosanol intake for reducing free radical production and preventing detrimental physiological function from excessive weight loss with high intensity exercise has not been examined. Thus, the purpose of this study was to investigate the effects of octacosanol supplementation during acute weight loss with high-intensity exercise training on lipid profiles and markers of oxidative stress in taekwondo players.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • at least 3 years of experience in national taekwondo competitions
  • abstain from caffeinated drinks, alcohol, and antioxidant supplements during the whole period of the study

Exclusion criteria

  • no history of chronic use of antioxidants, chronic aspirin, and nonsteroidal anti-inflammatory drugs (NSAIDs)
  • No cardiovascular, neurological, metabolic or renal diseases
  • no musculoskeletal injuries

Treatment and study plan

Octacosanol

Dietary Supplement

One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day

Placebo

Dietary Supplement

A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement

Primary outcomes

  1. Triglycerides

    Time frame: 6 days

    Plasma triglyceride levels

  2. Total Cholesterol

    Time frame: 6 days

    Plasma total cholesterol levels

  3. High-density Lipoprotein

    Time frame: 6 days

    Plasma levels of high-density lipoprotein

  4. Low-density Lipoprotein

    Time frame: 6 days

    Plasma levels of low-density lipoprotein

Secondary outcomes

  1. Malondialdehyde

    Time frame: 6 days

    Plasma levels of malondialdehyde

  2. Superoxide Dismutase

    Time frame: 6 days

    Plasma levels of superoxide dismutase

  3. Glutathione Peroxidase

    Time frame: 6 days

    Plasma levels of glutathione peroxidase

Sponsors and collaborators

Lead sponsor

Kosin University

Other

Collaborators

  • University of Nebraska

Registry information

Official study title

Octacosanol Supplementation Improves Lipid Profiles and Oxidative Stress During Rapid Weight Loss and High-Intensity Exercise in Taekwondo Athletes

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jun 15, 2018
Registry last updated
Nov 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.